Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension
Status:
Not yet recruiting
Trial end date:
2023-07-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy and safety of LTP001 in participants
with pulmonary arterial hypertension (PAH) to determine if LTP001 has an adequate clinical
profile to warrant further clinical development in this indication.